Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnaby Nelson

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
Behaviour Research and Therapy|December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trialJessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
JAMA Network Open|August 5, 2025
Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for PsychosisJohanna Seitz-Holland, Grace R Jacobs, Jenna Reinen, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2022
The lived experience of psychosis: a bottom-up review co-written by experts by experience and academicsPaolo Fusar-Poli, Andrés Estradé, Giovanni Stanghellini, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
Behaviour Research and Therapy|December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trialJessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
JAMA Network Open|August 5, 2025
Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for PsychosisJohanna Seitz-Holland, Grace R Jacobs, Jenna Reinen, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2022
The lived experience of psychosis: a bottom-up review co-written by experts by experience and academicsPaolo Fusar-Poli, Andrés Estradé, Giovanni Stanghellini, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Pageof 32